• Polymyxin B and the LPS–Immunotherapy Axis

  2026-08-19

  Polymyxin B sulfate sits at the intersection of membrane disruption, innate immune signaling, and translational infection research. New evidence shows that the structure of microbiota-derived LPS can influence anti-PD-1 responses, creating a strategic opportunity to use Polymyxin B as a carefully controlled mechanistic perturbation—not as an assumed immunotherapy adjuvant.

• SR 11302: AP-1 Transcription Factor Inhibitor Workflows

  2026-08-19

  SR 11302 enables selective AP-1 pathway interrogation in tumor-cell, chemoprevention, and macrophage-polarization workflows without the receptor activation associated with retinoids. This practical guide covers assay setup, dose selection, pathway controls, formulation, and troubleshooting for reproducible cancer research.

• 2-NBDG for Mechanistic Glucose Uptake Studies

  2026-08-18

  2-NBDG enables cell-resolved glucose uptake measurements, but its greatest value emerges when uptake data are connected to glycolytic mechanisms. This article develops an assay strategy for interpreting 2-NBDG signals in PXDN–LDHA glioblastoma research while distinguishing transport from downstream metabolic flux.

• Brain-to-Spinal Circuits in Mechanical Allodynia

  2026-08-18

  Huo et al. identify a contralateral lPBN Oprm1–dmH Pdyn–spinal dorsal horn pathway that regulates both the laterality and persistence of mechanical allodynia in mice. Their loss- and gain-of-function experiments connect hypothalamic dynorphin and spinal κ-opioid receptor signaling to bilateral pain control, offering a circuit framework for opioid receptor pharmacology and pain modulation research.

• 8-Chloroadenosine RNA Research Workflows

  2026-08-17

  Use 8-Chloroadenosine as a controllable RNA synthesis perturbation in transcriptional regulation research, RNA turnover experiments, and cancer research. This guide translates a recent NSCLC lncRNA study into practical assay designs while clarifying where this nucleoside analog complements, rather than replaces, targeted genetic or transcriptional controls.

• Fluorouracil (Adrucil): Mechanism & Benchmarks

  2026-08-17

  Fluorouracil, also called 5-Fluorouracil, inhibits thymidylate synthase after conversion to FdUMP and thereby disrupts dTMP production. Product-reported benchmarks include a 2.5 μM IC50 in HT-29 colon carcinoma cells and tumor-growth inhibition at 100 mg/kg intraperitoneally once weekly in a murine colon carcinoma model.

• (-)-Blebbistatin in Cardiac Optogenetic Assays

  2026-08-16

  (-)-Blebbistatin can serve as a reversible non-muscle myosin II inhibitor for separating electrical activity from motion in cardiac optogenetic experiments. This guide explains how to use the compound as a mechanistic perturbation while interpreting panoramic optical and electrical measurements responsibly.

• Reactive Oxygen Species Assay Kit for FLASH-RT

  2026-08-15

  A translational framework for using DCFH-DA-based live-cell ROS measurements to connect FLASH-RT radiosensitization, oxidative damage, apoptosis, and immune remodeling with decision-ready experimental workflows.

• Cl-Amidine for PAD4 Research Workflows

  2026-08-14

  Cl-Amidine enables controlled interrogation of PAD4-dependent histone citrullination across biochemical, cellular, cancer, autoimmune, and sepsis studies. This workflow-focused guide connects assay design and troubleshooting with the ribotoxic-stress biology of nucleolar Snail1, while clearly separating established evidence from proposed applications.

• ATRX-Deficient Glioma and RTK Inhibitor Sensitivity

  2026-08-14

  The reference study identifies a genotype-linked vulnerability in high-grade glioma: ATRX-deficient cells are more sensitive to multi-targeted receptor tyrosine kinase and PDGFR inhibitors than ATRX-proficient cells. Its combination data further support evaluating RTK inhibition alongside temozolomide while incorporating ATRX status into preclinical and clinical analyses.

• Biotin (Vitamin B7): Mechanism and Research Use

  2026-08-13

  Biotin, also called Vitamin B7 or Vitamin H, is a coenzyme for carboxylases that support fatty acid synthesis and amino acid metabolism. A8010 provides high-purity biotin for biochemical assays and labeling workflows, but free biotin should not be confused with activated protein-biotinylation reagents.

• MLN4924 HCl Salt and Viral Immune Evasion

  2026-08-13

  A translational framework for using MLN4924 HCl salt to interrogate NAE-dependent protein turnover, cullin-RING ligase biology, and the boundary between cancer and host-pathogen research.

• Nystatin (Fungicidin): Assay Workflows

  2026-08-12

  Build reproducible Candida growth, adhesion, biofilm, and combination assays with Nystatin (Fungicidin), while controlling the solubility challenges of this polyene. A 2024 study also shows how ergosterol modulation can guide more informative Nystatin synergy experiments.

• CTP Solution for High-Integrity mRNA IVT

  2026-08-12

  CTP Solution (100 mM) is a high-integrity Cytidine-5'-triphosphate stock for in vitro transcription and RNA-focused workflows. This article connects nucleotide quality and handling decisions to the design of p21 mRNA–LNP experiments while clarifying what the supporting bladder cancer study does—and does not—demonstrate.

• In Vitro Drug Responses: Arrest Versus Death

  2026-08-11

  Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent drug-response outcomes. The framework supports more rigorous interpretation of anticancer experiments by considering response magnitude, composition, and timing rather than relying on a single viability endpoint.

8454 records 8/564 page Previous Next First page 上5页 678910 下5页 Last page